Galenicum Annual Report 2020 FIND OUT This is Galenicum Galenicum was founded in Barcelona in 2003 by three friends in their twenties. Their mission was to provide quality and affordable Active Pharmaceutical Ingredients (APIs) to the Spanish pharmaceutical industry, emerging in the area of generics at that time. Since then, the company has grown significantly to become a global ecosystem of several businesses within the pharmaceutical, food and nutritional supplement sectors, with current commercial footprint in over forty countries. Galenicum remains committed to its original purpose of improving the quality and affordability of medicine: A non-stop challenge in becoming a global specialty pharmaceutical company. Galenicum covers the full pharmaceutical value chain, including: • Trading of Active Pharmaceutical Ingredients (APIs), • Intellectual property and patents, • Research and Development of Finished Dosage Forms (FDFs), • Regulatory affairs, • Manufacturing, • Supply and Commercialisation. BELIEVE IN LIFE 'Believe in life' has been our company tag line for many years now and it is a statement of hope for people around the world who are facing health issues and, for whom, we devote our talent and effort here at Galenicum. 'Believe in life' is also a good reflection of our company's ‘can do’ and forward-looking attitude, which is truly embedded within our culture, well-present in our daily work. UN DÍA EN GALENICUM We are ready to face new challenges The history of our company is proof of this. We respect and take care of our relationships Partners, customers and suppliers; we are all people beyond our roles in the workplace. We are full of energyPassionate and strongly committed to our company's projects and growth. We embrace change and adapt We understand change as an opportunity. We listen and adapt to keep improving. We use high doses of creativity Remarkable at our R&D department, but truly spread across all areas in the organisation. Our Story An adventure that started over 15 years ago to make high-quality affordable medicine: A non- stop challenge in becoming a global specialty pharmaceutical company. 2003 2003 Galenicum founded in Barcelona 2007 First authorisation received for generic products in Spain 2009 Granting of the first patent to Galenicum 2010 Incorporation of the GSI subsidiary for food ingredients 2012 Setting up business in Chile, Peru and Brazil 2013 Acquisition of a manufacturing plant 2014 Recognised as 'Business of the Year' in the European Business Awards 2015 Dermatalogical business incorporated 2016 Launch of food supplement range 2018 First Galenicum-developed product approved by the USFDA Setting up business in Colombia 2019 Setting up business in Ecuador 2020 New growth plans: Doubling of revenues to reach 240 Million Euro by 2024 2020 FOLLOW US AT Copyright © 2021 Galenicum WEBGLN0002-00;10/2019 THIS IS GALENICUM OUR BUSINESS OUR FOOTPRINT WORKING WITH US SOCIAL IMPACT CONTACT US Legal notice Privacy Policy Cookies